Phytothérapie

, Volume 15, Issue 6, pp 332–338 | Cite as

Alkékenge : Physalis alkekengi L. (Solanaceae)

Matière Médicale

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    The Plant List. http://www.theplantlist.org/tpl1.1/search?q=Physalis+alkekengi+Google Scholar
  2. 2.
    Cronquist A (1981) An integrated system of classification of flowering plants. Columbia University Press, New YorkGoogle Scholar
  3. 3.
    Frohne D, Pfänder HJ, Anton R (2009) Plantes à risques. Lavoisier/Tech &Doc/EM Inter, ParisGoogle Scholar
  4. 4.
    Wikipédia: https://fr.wikipedia.org/wiki/Physalis_alkekengiGoogle Scholar
  5. 5.
    http://luirig.altervista.org/cpm/albums/bot-009/physalis-alkekengi10440.jpgGoogle Scholar
  6. 6.
    https://upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Physalis_alkekengi_%28Echte_lampionplant%29.jpg/484px- Physalis_alkekengi_%28Echte_lampionplant%29.jpgGoogle Scholar
  7. 7.
    Sijelmassi A (2003) Les plantes médicinales du Maroc. Éditions Le FennecGoogle Scholar
  8. 8.
    Feng X, Liu H, Chai L, et al (2017) Metabolic profiles of physalin A in rats using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1046:102–109CrossRefPubMedGoogle Scholar
  9. 9.
    Xing F, Jiang J (2013) Chemical constituents in the calyx of Physalis alkekengi var. franchetii. Yao Xue Yu Lin. Chuang Yan Jiu Pharmaceutical and clinical research 21:344–6Google Scholar
  10. 10.
    Li J, Li D (2002) Studies on the chemical constituents of Physalis Alkekengi L. var. francheti (mast.) Makino (I). Zhong Cao Yao 33:6923Google Scholar
  11. 11.
    Lin F, Wang J (2011) Chemical constituents of physalins from dried calyx of Physalis alkekengi var. franchetii. Xian Dai Yao Wu Yu Lin Chuang 26:469–72Google Scholar
  12. 12.
    Xu D, Wang B, Zhou L, Kang TG (2009) Chemical constituents of Physalis alkekengi var. franchetii. Zhong Cao Yao 40:175–8Google Scholar
  13. 13.
    Li X, Zhao J, Yang M, et al (2014) Physalins and withanolides from the fruits of Physalis alkekengi L. var. franchetii (Mast.) Makino and the inhibitory activities against human tumor cells. Phytochem Lett 10:95–100CrossRefGoogle Scholar
  14. 14.
    Qiu L, Zhao F, Jiang ZH, et al (2008) Steroids and flavonoids from Physalis alkekengi var. franchetii and their inhibitory effects on nitric oxide production. J Nat Prod 71:642–6CrossRefPubMedGoogle Scholar
  15. 15.
    Yang YK, Xu WX, Nian Y, et al (2016) Six new physalins from Physalis alkekengi var. franchetii and their cytotoxicity and antibacterial activity. Fitoterapia 112: 144–52CrossRefPubMedGoogle Scholar
  16. 16.
    Chen CY, Peng WH, Tsai KD, et al (2007). Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci 81:1602–14CrossRefPubMedGoogle Scholar
  17. 17.
    Matsuura T, Kawai M, Nakashima R, et al (1969) Bitter principles of Physalis alkekengi var Francheti: structure of physalin A. Tetrahedron Lett 10:1083–6CrossRefGoogle Scholar
  18. 18.
    Sunayama R, Kuroyanagi M, Umehara K, et al (1993) Physalin and neophysalins from Physalis alkekengi var. francheti and their differentiation inducing activity. Phytochemistry 34:529–33CrossRefGoogle Scholar
  19. 19.
    Li K, Diao Y, Wang M, et al (2010) Chemical constituents of the fruits of Physalis alkekengi L. var. franchetii (mast.) Makino. Chin J Org Chem 30:128–31Google Scholar
  20. 20.
    Sharma NK, Kulshreshitha DK, Tandon JS, et al (1974) Two new sterols from Physalis franchetii fruit. Phytochemistry 13:2239–45CrossRefGoogle Scholar
  21. 21.
    Cai Q, Liu Y, Ma Z (2009) Isolation and identification of chemical constituents from the fruit and calyx of Physalis alkekengi L. var. franchetii (mast.) Makino. Shenyang Yao Ke Da Xue Xue Bao 26:807–10Google Scholar
  22. 22.
    Lin F, Wang J (2011) Chemical constituents of physalins from dried calyx of Physalis alkekengi var. franchetii. Xian Dai Yao Wu Yu Lin Chuang 26:469–72Google Scholar
  23. 23.
    Asano N, Kato A, Kizu H, et al (1996) 1β-amino-2α, 3β, 5β-trihydroxycycloheptane from Physalis alkekengi var. francheti. Phytochemistry 42:719–21CrossRefGoogle Scholar
  24. 24.
    Shu Z, Xu B, Xing N, et al (2014) Chemical constituents of Physalis calyx seu fructus. Zhong Guo Shi Yan Fang. Ji Xue Za Zhi 20:99–102Google Scholar
  25. 25.
    Zhang CY, Luo JG, Liu RH, et al (2016) 1H NMR spectroscopyguided isolation of new sucrose esters from Physalis alkekengi var. franchetii and their antibacterial activity. Fitoterapia 114:138–43CrossRefPubMedGoogle Scholar
  26. 26.
    Li X, Guang G, Zhang C, et al (2014) Improvement of intestinal microflora balance by polysaccharide from Physalis alkekengi var. francheti. Molecular Med Reports 9:677–82CrossRefGoogle Scholar
  27. 27.
    Li AL, Chen BJ, Li GH, et al (2018) Physalis alkekengi L. var. franchetii (Mast.) Makino: an ethnomedical, phytochemical and pharmacological review. J Ethnopharmacol 210:260–74CrossRefPubMedGoogle Scholar
  28. 28.
    Lou Z, Wang H, Zhu S, et al (2011) Antibacterial activity and mechanism of action of chlorogenic acid. J Food Sci 76: M398–M403CrossRefPubMedGoogle Scholar
  29. 29.
    Li L, Wang J, Wang Y, et al (2005) Anti-virus activities of the extract and effective components isolated from Senecio cannabifolius less, Chin J Basic Med. Tradit Chin Med 11:585–7Google Scholar
  30. 30.
    Zhang CY, Luo JG, Liu RH, et al (2016) 1H NMR spectroscopyguided isolation of new sucrose esters from Physalis alkekengi var. franchetii and their antibacterial activity. Fitoterapia 114:138–43CrossRefPubMedGoogle Scholar
  31. 31.
    Sá MS, de Menezes MN, Krettli AU, et al (2011) Antimalarial activity of physalins B, D, F, and G. J Nat Prod 74:2269–72CrossRefPubMedGoogle Scholar
  32. 32.
    Xin X, Liu F, Huang S, et al (2010) vitro anti lung cancer effect of Physalis alkekengil L. var. francheti (mast.). Zhongguo Lao Nian Yi Xue Za Zhi 30:2486–7Google Scholar
  33. 33.
    Kang N, Jian JF, Cao SJ, et al (2016) Physalin A induces G2/M phase cell cycle arrest in human non-small cell lung cancer cells: involvement of the p38 MAPK/ROS pathway. Mol Cell Biochem 415:145–55CrossRefPubMedGoogle Scholar
  34. 34.
    Zhu F, Dai C, Fu Y, et al (2016) Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling. Oncotarget 7:9462–76CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Dornberger K (1986) The potential antineoplastic acting constituents of Physalis alkekengi L. var. franchetii Mast. Pharmazie 41:265–8PubMedGoogle Scholar
  36. 36.
    Laczkó-Zöld E, Forgó P, Zupkó I, et al (2017) Isolation and quantitative analysis of physalin D in the fruit and calyx of Physalis alkekengi. Acta Biol Hung 68:300–9CrossRefPubMedGoogle Scholar
  37. 37.
    Guo Y, Li S, Li J, et al (2017) Anti-hyperglycemic activity of polysaccharides from calyx of Physalis alkekengi var. franchetii Makino on alloxan-induced mice. Int J Biol Macromol 99:249–57CrossRefPubMedGoogle Scholar
  38. 38.
    Zhao X, Chen Z, Yin Y, Li X (2017) Effects of polysaccharide from Physalis alkekengi var. francheti on liver injury and intestinal microflora in type-2 diabetic mice. Pharm Biol 55:2020–5CrossRefPubMedGoogle Scholar
  39. 39.
    Beiraghdar F, Einollahi B, Ghadyani A, et al (2017) A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men. Pharm Biol 55:1800–5CrossRefPubMedGoogle Scholar
  40. 40.
    Changizi-Ashtiyani S, Alizadeh M, Najafi H, et al (2016) Physalis alkekengi and Alhagi maurorum ameliorate the side effect of cisplatin-induced nephrotoxicity. Cancer Gene Ther 23:235–40CrossRefPubMedGoogle Scholar
  41. 41.
    Shu Z, Xing N, Wang Q, et al (2016) Antibacterial and antiinflammatory activities of Physalis Alkekengi var. franchetii and its main constituents. Evid Based Complement Alternat Med Article ID 4359394, 10 pages. http://dx.doi.org/10.1155/2016/4359394Google Scholar
  42. 42.
    Namjoyan F, Jahangiri A, Azemi ME, et al (2015) Inhibitory effects of Physalis alkekengi L., Alcea rosea L., Bunium persicum B. Fedtsch. and Marrubium vulgare L. on Mushroom tyrosinase. Jundishapur J Nat Pharm Prod 10:e23356Google Scholar
  43. 43.
    Yang J, Yang F, Yang H, et al (2015) Water soluble polysaccharide isolated with alkali from the stem of Physalis alkekengi L.: structural characterization and immunologic enhancement in DNA. Carbohydr Polym 121:248–53CrossRefPubMedGoogle Scholar
  44. 44.
    Li X, Zhang C, Li W, et al (2013) In vivo effects on the intestinal microflora of Physalis alkekengi var. francheti extracts. Fitoterapia 87:43–8CrossRefPubMedGoogle Scholar
  45. 45.
    Vessal M, Rasti M, Kooshesh F (1996) Modulation of the pituitary and basomedial hypothalamic lysyl-aminopeptidase activities be beta-estradiol and/or an aqueous extract of Physalis alkekengi fruits. Comp Biochem Physiol B Biochem Mol Biol 115:267–71CrossRefPubMedGoogle Scholar
  46. 46.
    Liu AL, Pan Z, Zhuang X, et al (2008) Effect and mechanism of aqueous extract of Physalis Alkekengil L. var. francheti (mast.) on thoracic aorta in rats. Zhong Cao Yao 39:1709–12Google Scholar
  47. 47.
    Wu L, Cai Y, Chang L (2012) Study on the diuresis of alcohol extractive of calyx seu fructus Physalis. J Mudanjiang Med Univ 33:5–6Google Scholar
  48. 48.
    Agence du médicament (1998) Les cahiers de l’Agence: médicaments à base de plantesGoogle Scholar

Copyright information

© Lavoisier 2017

Authors and Affiliations

  1. 1.faculté de pharmacie de MonastirLaboratoire de pharmacognosieMonastirTunisie
  2. 2.DU de phytothérapieParis-XIIIBobigny cedexFrance

Personalised recommendations